The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients.
Source: Care Giving Science Daily
Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke
February 7th, 2019 | Posted by in UncategorizedYou can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.
Leave a Reply